Document:

Asset Purchase Agreement

 Exhibit 10.1 
 ASSET PURCHASE AGREEMENT 
 dated as of April 6, 2006 
 by and among 
 MEDICINE MADE EASY 

and 
 H&H DRUG STORES, INC. 

THE YOUREDJIAN FAMILY TRUST 
 H&H DRUG
STORES, INC. EMPLOYEE STOCK OWNERSHIP TRUST 
 HAGOP YOUREDJIAN 

 ASSET PURCHASE AGREEMENT 
 This ASSET PURCHASE AGREEMENT dated as of April 6, 2006, is by and between MEDICINE MADE EASY, a California corporation (“Buyer”), and
H&H DRUG STORES, INC., a California corporation d/b/a Western Drug (“Seller”), HAGOP YOUREDJIAN and ZARIG YOUREDJIAN, as Trustees of THE YOUREDJIAN FAMILY TRUST and H&H DRUG STORES, INC. EMPLOYEE STOCK OWNERSHIP TRUST (the
“Seller’s Shareholders”), and HAGOP YOUREDJIAN, and ZARIG YOUREDJIAN. 
 Seller is a licensed California pharmacy located at
3604 San Fernando Road, Glendale, California 91204 (the “Pharmacy”). 
 Buyer desires to purchase and Seller desires to sell,
transfer and deliver to Buyer Seller’s right title and interest in and to certain of its business and assets related to Seller’s HIV/AIDS business (the “HIV/AIDS Business”), including without limitation its inventory, customer
lists, prescription files, books and records, files and goodwill, in each case related to the HIV/AIDS Business, on the terms and conditions set forth in this Agreement. 
 The parties agree as follows: 
 ARTICLE I 
 DEFINITIONS 
 The terms defined in this Article I, whenever used herein
(including the schedules hereto, unless otherwise defined therein), shall have the following meanings: 
 1.1 “Additional
Payments” shall have the meaning set forth in Section 2.2(a)(ii) of this Agreement 
 1.2 “Affiliate” shall
mean any Person that directly or indirectly controls, is controlled by or is under common control with another Person. 
 1.3
“Acquired Assets” shall mean (i) all of Seller’s right, title and interest in and to the customer list for its HIV/AIDS Business, as posted on internet web page of Provident Health Partners, LLC., at
https://www.providenthp.com/myprovident/companies.php, on April 6, 2006 (the “Customer List”), as well as all other information, including without limitation names, addresses, referring physicians, documents,
Prescription Files, other files and records, and goodwill, in each case relating or pertaining only to the customers listed on the Customer List, and (ii) all of the Inventory. 
 1.4 “Business Day” shall mean any day other than a Saturday, Sunday or other day on which banks are closed or are authorized to be
closed in New York, New York. 
 1.5 “Buyer Claimant” shall have the meaning set forth in Section 8.2 of this Agreement. 

 1.6 “Closing” shall have the meaning set forth in Section 3.1 of this Agreement.

 1.7 “Closing Date” shall have the meaning set forth in Section 3.1 of this Agreement. 
 1.8 “Code” shall mean the Internal Revenue Code of 1986, as amended. 
 1.9 “Contract” shall have the meaning set forth in Section 4.3 of this Agreement. 
 1.10 “Employee Benefit Plan” means any “employee benefit plan” within the meaning of Section 3(3) of ERISA, and any other
bonus, profit sharing, compensation, pension, severance, deferred compensation, fringe benefit, insurance, welfare, medical, post-retirement health or welfare benefit, medical reimbursement, health, life, stock option, stock purchase, tuition
refund, service award, company car, scholarship, relocation, disability, accident, sick pay, sick leave, vacation, termination, individual employment, executive compensation, incentive, bonus, commission, payroll practices, retention or other plan,
agreement, policy, trust fund or arrangement, whether written or unwritten, and whether maintained, sponsored or contributed to by Seller or any entity that would be deemed a “single employer” with Seller under Section 414(b), (c),
(m) or (o) of the Code or Section 4001(a)(14) of ERISA (an “ERISA Affiliate”) on behalf of any of the current, former or retired employees of Seller or its beneficiaries or with respect to which Seller or any ERISA Affiliate
has or has had any obligation on behalf of any such employee or beneficiary. 
 1.11 “Encumbrance” shall mean any lien,
charge, encumbrance, option, right of first refusal, security interest, easement, obligation or claim or other third party right of any kind. 
 1.12 “Environment” shall mean any surface or subsurface physical medium or natural resource, including, air, land, soil, surface waters, ground waters, stream and river sediments, and biota. 
 1.13 “Environmental Laws” shall mean any federal, state, local or foreign law, rule, regulation, ordinance, code, order or judgment
(including the common law and any judicial or administrative interpretations, guidances, directives or opinions) relating to the injury to, or the pollution or protection of human health and safety or the Environment. 
 1.14 “Environmental Liabilities” shall mean any claims, judgments, damages (including punitive damages), losses, penalties, fines,
liabilities, encumbrances, liens, violations, costs and expenses (including attorneys and consultants fees) of investigation, remediation or defense of any matter relating to human health, safety or the Environment of whatever kind or nature by any
party, entity or authority, (a) which are incurred as a result of (i) the existence of Hazardous Substances in, on, under, at or emanating from any real property presently or formerly owned or operated by Seller or any of its Affiliates,
(ii) the offsite transportation, treatment, storage or disposal of Hazardous Substances generated by Seller or any of its Affiliates, or (iii) the violation of any Environmental Laws or (b) which arise under the Environmental Laws.

 1.15 “ERISA” shall mean the Employee Retirement Income Security Act of 1974, as amended, and the regulations thereunder.

  

 2 

 1.16 “ERISA Affiliate” shall have the meaning set forth in the definition of
“Employee Benefit Plan”. 
 1.17 “Excluded Liabilities” shall have the meaning set forth in Section 2.1(c) of
this Agreement. 
 1.18 “Financial Statements” shall mean (a) the unaudited financial statements of the Seller as of
December 31, 2002, 2003 and 2004, and for each of the fiscal years then ended, and (b) the unaudited financial statements of the Seller as of December 31, 2005, and for the fiscal year then ended. 
 1.19 “GAAP” shall mean generally accepted accounting principles. 
 1.20 “Hazardous Discharge” shall mean any releasing, spilling, leaking, pumping, pouring, emitting, emptying, discharging, injecting,
escaping, leaching, migrating, disposing or dumping (including the movement of any material through or in air, soil, surface or groundwater) of Hazardous Substances, whether on, off, under or from any real property owned, operated, leased or used at
any time by Seller or its predecessors. 
 1.21 “Hazardous Substances” shall mean petroleum, petroleum products,
petroleum-derived substances, radioactive materials, hazardous wastes, polychlorinated biphenyls, lead based paint, urea formaldehyde, asbestos or any materials containing asbestos, and any materials, wastes or substances regulated or defined as or
included in the definition of “hazardous substances,” “hazardous materials,” “hazardous constituents,” “toxic substances,” “pollutants,” “contaminants” or any similar denomination intended
to classify substances by reason of toxicity, carcinogenicity, ignitability, corrosivity or reactivity under any Environmental Laws. 
 1.22
“Indemnitee” and “Indemnitor” shall have the meanings set forth in Section 8.4(a) of this Agreement. 
 1.23 “Initial Payment” shall have the meaning set forth in Section 2.2(a)(i) of this Agreement. 
 1.24
“Inventory” means all items of Seller’s inventory related to the HIV/AIDS Business, provided that an item shall be considered “Inventory” only if Seller has provided to Buyer at or prior to the Inventory Date the
following information for such item: (a) the proprietary and established name of the item; (b) dosage; (c) container size; (d) number of containers; (e) the item’s lot or control number(s); (f) the business name
and address of all parties to each prior transaction involving the item, starting with the manufacturer; and (g) the date of each previous transaction. 
 1.25 “Inventory Date” shall mean a date no later than ten (10) following the Closing Date mutually acceptable to Buyer and Seller, when representatives of Buyer and Seller shall jointly make a
physical inspection of the Inventory, at the offices of the Seller, and determine the amount of the Inventory Payment. 
 1.26
“Inventory Payment” shall have the meaning given such term in Section 2.2(b) of this Agreement. 
  

 3 

 1.27 “IRS” shall mean the Internal Revenue Service. 
 1.28 “Licenses and Permits” shall have the meaning set forth in Section 4.13 of this Agreement. 
 1.29 “Losses” shall have the meaning set forth in Section 8.2 of this Agreement. 
 1.30 “Material Adverse Effect” shall mean any material adverse effect, individually or in the aggregate, on the condition (financial or
otherwise), business, assets, operations or prospects of Seller or the Acquired Assets. 
 1.31 “Payment Program” shall have
the meaning set forth in Section 4.18 of this Agreement. 
 1.32 “Person” shall mean any natural person, corporation,
professional corporation, limited or limited liability partnership, general partnership, joint venture, association, joint-stock company, limited liability company, company, trust, bank, trust company, land trust, business trust or other
organization, whether or not a legal entity, and any governmental unit or agency or political subdivision thereof. 
 1.33
“Prescription Files” shall mean all prescription files owned or used by Seller that are associated with the HIV/AIDS Business, and all customer data and information derived from customer purchases from Seller. 
 1.34 “Purchase Price” shall have the meaning set forth in Section 2.2(b) of this Agreement. 
 1.35 “Real Property” shall mean the real property and interests in real property described on Schedule 4.16 leased by Seller and the
plants, buildings, structures, storage tanks, erections and improvements of all kinds made to, located on or forming a part of the real property and interests in real property (including, without limitation, all fixtures), together with all
easements, rights-of-way, appurtenances and tenements to, on or otherwise beneficial to the use of such real property or interests in real property. 
 1.36 “Related Party” shall have the meaning set forth in Section 4.12 of this Agreement. 
 1.37 “Seller Claimant” shall have the meaning set forth in Section 8.3 of this Agreement. 
 1.38
“Taxes” (or “Tax” where the context requires) shall mean all federal, state, local, foreign or other taxes, duties, or similar charges (including, without limitation, income (whether net or gross), profits, premium,
estimated, excise, sales, use, environmental (including taxes under Code Section 59A), occupancy, franchise, license, value added stamp, windfall profits, social security, gross receipts, franchise, ad valorem, severance, capital levy,
production, transfer, gains, withholding, occupation, employment and payroll related and property taxes, alternative or add-on, minimum or estimated, import and export duties and other governmental charges and assessments) imposed by any taxing or
governmental authority on or payable by Seller or any other party with 
  

 4 

 respect to the income, operations, products, assets or properties of Seller, whether attributable to statutory or
nonstatutory rules and whether or not measured in whole or in part by net income, and including interest, additions to tax or interest, and penalties with respect thereto, and including expenses associated with contesting any proposed adjustment
related to any of the foregoing. 
 ARTICLE II 
 SALE AND PURCHASE OF THE ACQUIRED ASSETS  
 2.1 Purchase of the Acquired Assets. 

(a) Upon the terms and subject to the conditions hereof, and upon the basis of the agreements, representations and warranties contained in, and the
schedules to, this Agreement, at the Closing, Seller shall sell, transfer, assign, convey and deliver to Buyer, and Buyer shall purchase and acquire from Seller, all of the Acquired Assets, in each case free and clear of Encumbrances of any kind.

 (b) Notwithstanding anything contained in this Agreement, Seller shall not sell, transfer, assign, convey or deliver to Buyer, and Buyer
shall not purchase or acquire from Seller, (i) any of Seller’s cash or accounts receivable, (ii) any of Seller’s equipment, agreements, furniture or fixtures, (iii) any of Seller’s Contracts, (iv) any of
Seller’s other assets other than the Acquired Assets or (v) any of Seller’s assets related primarily to any of its business other than the HIV/AIDS Business. 
 (c) Buyer shall not be required to assume, pay, fulfill, perform or otherwise discharge any liabilities or obligations of Seller, including of
Seller’s business, of any kind whatsoever (the “Excluded Liabilities”), and Seller shall pay, fulfill, perform and discharge such Excluded Liabilities when due. The Excluded Liabilities include, without limitation: 
 (i) Legal, accounting, brokerage, finder’s fees, Taxes or other expenses incurred by Seller or any Affiliate, including, without limitation, in
connection with this Agreement or the consummation of the transactions contemplated hereby; 
 (ii) Any intercompany debt or other liability
or obligation of any nature between Seller and any past or present Related Party of Seller; 
 (iii) Liabilities or obligations incurred by
Seller or any Affiliate of Seller after the Closing; 
 (iv) Any obligation or liability relating to any litigation or any claim arising out
of any dispute, the elements of which occurred prior to the Closing, or any litigation or other claim against Seller, whether or not listed on any schedule hereto and regardless of whether accruing prior to or subsequent to the Closing; 

(v) Any liability for any Taxes accrued to or incurred by Seller or any Affiliate of Seller or relating to operations, products or assets of Seller
or any Affiliate of Seller or arising as a consequence of the transactions contemplated hereby; 
  

 5 

 (vi) Any liability or costs (including, without limitation, costs of remediation) arising out of or
relating to a Hazardous Discharge or the release, discharge or disposal of any solid wastes or the handling, storage, use, transportation or disposal of any of the foregoing, as these terms are defined by the Environmental Laws in, on, under or from
facilities of Seller at any time prior to the Closing, regardless of whether such liability or costs arise before or after Closing and whether or not in breach of any representation or warranty under this Agreement; 
 (vii) Any liability or obligation to employees, government agencies or other third parties in connection with any option plan, pension plan, other ERISA
plan or other Employee Benefit Plan, and any health, dental or life insurance benefits, whether or not insured and whether or not disclosed on any schedule hereto; 
 (viii) Any liability or obligation under any contract or commitment, and any liability or obligation which relates to any default in respect of such contract or other commitment or obligation of Seller; 
 (ix) Any liability or obligation to employees in the nature of accrued payroll, vacation, holiday or sick pay, worker’s compensation relating to
the period prior to the Closing, whether or not listed on any schedule hereto and regardless of whether accruing prior or subsequent to the Closing; 
 (x) Any trade debt, accounts payable, notes payable and bank debts; or 
 (xi) Any other liability, debt or
obligation of Seller or any of its Shareholders. 
 2.2 Purchase Price. 
 (a) In consideration for the Acquired Assets (other than the Inventory), Buyer shall pay to Seller an amount in cash equal to Four Million Six Hundred
Thousand Dollars ($4,600,000), payable as follow: 
 (i) At the Closing, Buyer shall pay to Seller and amount in cash equal to Three Million
Six Hundred Eighty Thousand Dollars ($3,680,000) (the “Initial Payment”); and 
 (ii) In addition, (i) on each of May 6,
2006, June 6, 2006, July 6, 2006 and August 6, 2006, Buyer shall pay to Seller an amount equal to Two Hundred Thirty Thousand Dollars ($230,000) (the “Additional Payments”) if, and only if, (x) Seller and
Seller’s management, including Seller’s Shareholders, have during the four (4) month period from the Closing Date through August 6, 2006 provided during normal business hours such reasonable assistance to Buyer as Buyer from time
to time has requested to transition the business of Seller and the Acquired Assets to Buyer (it being understood that the requirement to provide such assistance shall be considered satisfied by Hagop Youredjian, and/or Jessica Siu, Lillian Garcia,
Donna Marie Magsakay, and Yalpri Cuadra, writing a mutually satisfactory letter to Seller’s former HIV customers regarding the Buyer’s acquisition of the Acquired Assets, contacting such customers by telephone to advise them of the
transition to Buyer and assisting such customers with any 
  

 6 

 questions they may have, coordinating with Buyer’s information technology personnel the downloading of customer
records and information, and such other assistance as may reasonably be requested by Buyer to provide to Buyer the benefit of the Acquired Assets); and 
 (b) Within five (5) days following the Inventory Date, in consideration for the Inventory, Buyer shall pay to Seller an amount equal to Seller’s wholesale acquisition cost of the Inventory (as calculated by
Buyer based on documentation provided by Seller to Buyer), in each case only to the extent that such Inventory conforms to the representation contained in Section 4.6 (the “Inventory Payment” and, collectively with the Initial Payment
and the Additional Payments, the “Purchase Price”). Any Purchase Price payable under this Agreement shall be paid in cash, in immediately available funds, via bank wire transfer per Seller’s written instructions. 
 2.3 Allocation of Purchase Price. The Purchase Price for the Acquired Assets shall be allocated for federal, state, local and foreign tax purposes
by each party among the Acquired Assets as mutually determined by Seller and Buyer, in compliance with applicable laws and generally accepted accounting principles. For all pertinent tax purposes, each party hereto shall report the purchase and sale
provided for, and with the characterization given these transactions in this Agreement, to taxing authorities on a basis consistent with such allocation, and each party agrees not to take a position inconsistent with such allocation. After the
Closing, Seller and Buyer each shall timely file form 8594 with the IRS detailing this allocation. In the event that Buyer determines, subject to Seller’s reasonable approval, that any adjustments to such allocation are necessary, Seller shall
make such modifications as are necessary, reporting the same on Seller’s form 8594 (if required) or any tax report or return filed or to be filed by Seller in order to conform to Buyer’s allocation as adjusted. 
 ARTICLE III  
 CLOSING

 3.1 The Closings. Subject to the terms and conditions of this Agreement, the Closing of the purchase and sale of the Acquired
Assets (the “Closing”) shall occur on April 6, 2006 (the “Closing Date”), at the offices of Buyer’s counsel, Nixon Peabody LLP, 990 Stewart Avenue, Garden City, New York. 
 3.2 Obligations of Seller. At the Closing, Seller shall deliver to Buyer the following: 
 (a) A bill of sale, in customary form, duly executed by Seller. 
 (b) A legal opinion of counsel to Seller and Seller’s Shareholders, covering the matters set forth in Exhibit A. 
 (c) Copies of the resolutions of the Board of Directors and shareholders of Seller certified by the secretary or assistant secretary of Seller, which resolutions shall approve and authorize the execution and delivery
of this Agreement and the consummation of the transactions contemplated hereby. 
  

 7 

 (d) Any required consents to the assignment to Buyer of each of the Acquired Assets. 
 (e) Such other instruments of assignment and conveyance as may be necessary or appropriate to fully and effectively transfer to Buyer the Acquired
Assets. 
 (f) All of the other documents and instruments required to be delivered by Seller. 
 3.3 Obligations of Buyer. At the Closing, Buyer shall deliver to Seller the following: 
 (a) The Initial Payment. 
 (b) Copies of
the resolutions of the Board of Directors of Buyer certified by the secretary or assistant secretary of Seller, which resolutions shall approve and authorize the execution and delivery of this Agreement and the consummation of the transactions
contemplated hereby. 
 (c) All of the other documents and instruments required to be delivered by Buyer. 
 ARTICLE IV 
 REPRESENTATIONS AND WARRANTIES
REGARDING SELLER AND SELLER’S 
 BUSINESS 
 Seller and Seller’s Shareholders hereby represent and warrant to Buyer, as of the date hereof and as of the Closing, as follows: 
 4.1 Organization and Qualification. Seller is a corporation duly organized, validly existing and in good standing under the laws of the State of California, with full corporate power and authority to own, lease
and operate its properties and assets and to conduct its business as it is now being conducted. Seller has no Affiliates, subsidiaries or equity interest in any other Person. Seller is duly qualified and in good standing as a California corporation
and has all requisite corporate power and authority to do business in the State of California, which jurisdiction is the only jurisdiction wherein the character of the properties owned or leased or the nature of activities conducted by Seller make
such qualification necessary. Seller’s Shareholders own all the issued and outstanding capital stock of Seller. 
 4.2 Authority.
Seller has all requisite power and authority to execute and deliver this Agreement and all documents, certificates, agreements, instruments and writings related hereto to which it is a party and to perform, carry out and consummate the transactions
contemplated hereby and thereby. The execution, delivery and performance of this Agreement have been duly authorized by all necessary corporate action on the part of Seller. This Agreement has been duly and validly executed by Seller and constitutes
the legal, valid and binding obligations of Seller, enforceable against Seller in accordance with its terms. 
  

 8 

 4.3 No Breach. Neither the execution and delivery of this Agreement by Seller nor the consummation
of the transactions contemplated hereby will: (a) violate any provision of the Certificate of Incorporation or Bylaws of Seller; (b) conflict with, result in a breach of or constitute a default (or an event which, with or without notice,
lapse of time or both, would constitute a default) under any leases, agreements, instruments, arrangements, contracts, commitments or understandings, written or oral, to which Seller is a party or by which Seller or any of the Acquired Assets is
bound (collectively, the “Contracts”); (c) result in the creation of, or give any party the right to create, any Encumbrance upon any of the Acquired Assets; (d) conflict with, violate, result in a breach of or constitute a
default under any judgment, decree, order or process of any court or governmental authority; (e) conflict with or violate any statute, law or regulation applicable to Seller or any of the Acquired Assets; or (f) require Seller to obtain
any authorization, consent, approval or waiver from, or to make any filing with, any governmental or regulatory authority, or other third party. 
 4.4 Financial Statements and Sales Information. Prior to the date hereof, Seller has delivered to Buyer the Financial Statements, which are attached hereto as Schedule 4.4. The Financial Statements: (a) were prepared from the
books and records of Seller, which books and records have been maintained in accordance with all legal and accounting requirements and completely and accurately reflect all financial transactions of Seller, including, without limitation, the
accounts receivable, accounts payable and revenue of Seller for the periods covered by and as at the dates of the Financial Statements; (b) were prepared in accordance with GAAP consistently applied; and (c) are true and correct, and
present fairly the financial condition of Seller and the results of its operations for the periods covered by, and as at the dates of, each of the Financial Statements. The Financial Statements do not contain any material items of special or
non-recurring income or other income not earned in the ordinary course of business except as expressly specified therein. All liabilities (whether accrued, unmatured, contingent or otherwise, and whether due or to become due) of Seller are set forth
or adequately reserved against on the face of the most recent Financial Statements, except for liabilities incurred since the date thereof in the ordinary course of business as theretofore conducted, which liabilities are not, individually or in the
aggregate, materially adverse to the condition (financial or otherwise), business, assets, operations or prospects of Seller. Seller is neither aware nor ought reasonably to be aware of any basis for the assertion against Seller of any materially
adverse liability or loss contingency. Prior to the date hereof, Seller has provided Buyer with sales information, by HIV customer, for its past three fiscal years. Seller’s revenues for the year ended December 31, 2005, relating to the
Acquired Assets, were at least $11.6 million. The books and records of Seller are accurate and complete and have been maintained in accordance with good business practices. 
 4.5 Absence of Certain Changes or Events. Since December 31, 2004: Seller’s business has been conducted and the Acquired Assets have
been acquired and operated only in the ordinary and usual course consistent with past practice; neither Seller’s business nor the Acquired Assets have suffered any event or condition that has had a Material Adverse Effect; and Seller is not
aware of any event or condition that has occurred or would reasonably be expected to occur that could result in a Material Adverse Effect. 
 4.6 Acquired Assets. Seller has good and freely transferable title to all of the Acquired Assets, free and clear of all Encumbrances, and has the complete and unrestricted power and right to sell and transfer the Acquired Assets to
Buyer in accordance with the terms hereof. All 
  

 9 

 items included in the Inventory consist of a quality and quantity usable and saleable in the ordinary course of business
of Seller, and are not slow moving, damaged, below-standard quality or in excessive quantities. 
 4.7 [INTENTIONALLY OMITTED] 
 4.8 Contracts and Commitments. Schedule 4.8 is a list of all Contracts. Seller is not in breach or default, nor is there any basis for any valid
claim of breach or default by Seller, under any Contract. The Contracts are valid and in full force and effect and, assuming the obtaining of any consents to the assignment thereof, consummation of the transactions contemplated by this Agreement
will not cause any Contract to cease to be valid and in full force and effect. Accurate and complete copies of the Contracts, including all amendments thereto, have been heretofore delivered to Buyer. 
 4.9 Litigation, Etc. Except as set forth on Schedule 4.9, there has not been in the five years prior to the date hereof, nor is there currently,
any claim, action, suit, inquiry, proceeding or, to the best of Seller’s knowledge, investigation of any kind or nature whatsoever, by or before any court or governmental or other regulatory or administrative agency, commission or tribunal
brought, asserted or initiated by Seller, or pending or, to the best of Seller’s knowledge, threatened against or involving Seller and relating to or affecting the HIV/AIDS Business. To the best of Seller’s knowledge, there is no valid
basis for any such claim, action, suit, inquiry, proceeding or investigation. Seller is not subject to any judgment, order or decree. 
 4.10
Compliance with Law. Seller is and has been conducting its business, marketing and selling its services and/or products, and owning and operating all of its assets, in compliance in all material respects with all applicable laws, rules,
regulations, orders, codes, ordinances, authorizations, judgments and decrees, of all federal, state, local, foreign or other governmental or regulatory authorities. Seller and each of its employees or agents providing services at the pharmacy, as
applicable, (a) hold all permits, licenses, registrations, franchises, certificates, concessions and other governmental approvals and authorizations (the “Licenses and Permits”) required for the operation of Seller’s business,
including, without limitation, all Licenses and Permits required by federal, state and local law and all applicable regulatory agencies, and (b) are in compliance in all material respects with all applicable laws, regulations and agreements,
including without limitation the Health Insurance Portability and Accountability Act of 1996 as it relates to the maintenance of customer and patient lists and records. All such Licenses and Permits are in full force and effect and Seller is not in
default in any respect with respect to any such Licenses and Permits. No notice from any authority with respect to the revocation, termination, suspension or limitation of any such Licenses and Permits has been issued or given, nor is Seller aware
of the proposed or threatened issuance of any such notice. 
 4.11 Finders. Except as set forth on Schedule 4.11, neither Seller, nor
any of its Affiliates, nor any of Seller’s directors or officers, has taken any action that, directly or indirectly, would obligate Buyer or any of its Affiliates to anyone acting as broker, finder, financial advisor or in any similar capacity
in connection with this Agreement or any of the transactions contemplated hereby. 
  

 10 

 4.12 Related Party Transactions; Intercompany Accounts. Except as set forth on Schedule 4.12,
there are no Contracts between Seller, on one hand, and any shareholder, director, officer, employee, consultant or Affiliate of Seller (each, a “Related Party”), on the other, related to the HIV/AIDS Business. Set forth on Schedule 4.12
is a true and complete list of each transaction during the prior 18 months between Seller, on one hand, and any Related Party, on the other, related to the HIV/AIDS Business. 
 4.13 Tax Matters. All Taxes that are due or payable by Seller, whether or not disputed by Seller, have been paid in full. All tax returns to be
filed in connection with Taxes have been accurately prepared and duly and timely filed. Attached as Schedule 4.13 are true, complete and accurate copies of Seller’s Federal and state income tax returns for 2002, 2003 and 2004. 
 4.14 Improper Payments. Neither Seller, nor any of Seller’s officers and employees nor, to the best of Seller’s knowledge, Sellers
agents have made any illegal or improper payments to, or provided any illegal or improper benefit or inducement for, any governmental official, supplier, customer or other person, in an attempt to influence any such person to take or to refrain from
taking any action relating to Seller’s business. 
 4.15 Payment Programs. Neither Seller, nor any of its officers or employees,
nor, to the best knowledge of Seller, agents has received written notice that it is subject to any restriction or limitation on the receipt of payment under the Medicare, Medicaid or Medi-Cal programs, any other federally funded health care program
or any other third party payor (collectively, the “Payment Programs”). Seller has valid and current provider agreements with the Payment Programs. Seller is in compliance in all material respects with the conditions of participation for
the Payment Programs. Neither Seller, nor any of Seller’s officers or employees, nor, to the best knowledge of Seller, agents has received written notice that a Payment Program has requested or threatened any recoupment, refund or set-off from
Seller, or imposed any fine, penalty or other sanction on Seller, nor has Seller been excluded from participation in a payment program. Seller has not submitted to a Payment Program any false or fraudulent claim for payment, nor has Seller at any
time violated in any material respect any condition for participation, or any published rule, regulation, policy or standard of a Payment Program. 
 4.16 Fraud and Abuse. Neither Seller, nor any of Seller’s officers, employees or agents, has engaged in any activities that are prohibited under Federal Medicare and Medicaid statutes, 42 U.S.C. §§ 1320a-7, 1320a-7a,
I320a-7b or the Federal False Claims Act, 31 U.S.C. § 3729 et seq., the regulations promulgated pursuant to such statutes, or any related state or local statutes or regulations. 
 4.17 Physician Self-Referrals. Seller’s operations are in compliance in all material respects with and do not otherwise violate the Federal
Medicare and Medicaid statutes regarding physician self-referrals, 42 U.S.C. §§ 1395nn and I396b(s), the regulations promulgated pursuant to such statutes, or any related state or local statutes or regulations. Neither Seller, nor any of
Seller’s officers, employees or agents, has engaged in any activities that may violate such statutes or regulations. 
 4.18
Controlled Substances. Seller has not engaged in any activities which are prohibited under the Federal Controlled Substances Act, 21 U.S.C. § 801 et seq., or the regulations promulgated pursuant to such statute or any related state or
local statutes or regulations concerning the dispensing and sale of controlled substances. 
  

 11 

 4.19 Customers and Suppliers. Schedule 4.19 hereto sets forth a list of Seller’s fifteen
largest customer, referrers of customers and suppliers in order of dollar volume of sales, referrals and purchases, respectively, during its last three fiscal years, in each case related to the HIV/AIDS Business. There has not been any adverse
change and there are no facts known to Seller which may reasonably be expected to indicate that any adverse change may occur in the business relationship of Seller or, after the Closing, Buyer with any supplier or referral source named on Schedule
4.19. 
 4.20 [INTENTIONALLY OMITTED] 
 4.21 [INTENTIONALLY OMITTED] 
 4.22 Disclosure. No representation, warranty or other statement by Seller or Seller’s
Shareholders herein or made in writing in connection herewith contains or will contain an untrue statement of a material fact, or omits or will omit to state a material fact necessary to make the statements contained herein or therein not
misleading. 
 ARTICLE V 
 REPRESENTATIONS AND WARRANTIES REGARDING BUYER 
 Buyer hereby represents and warrants to Seller as follows: 
 5.1 Organization and Qualification. Buyer is a corporation duly organized, validly existing and in good standing under the laws of the State of
California, with full corporate power and authority to own, lease and operate its properties and assets and to conduct its business as it is now being conducted. 
 5.2 Authority. Buyer has all requisite power and authority to execute and deliver this Agreement and to perform, carry out and consummate the transactions contemplated hereby. The execution, delivery and
performance of this Agreement have been duly authorized by all necessary corporate action on the part of Buyer. This Agreement constitutes the legal, valid and binding obligations of Buyer, enforceable against Buyer in accordance with its terms.

 5.3 No Breach. Neither the execution and delivery of this Agreement by Buyer nor the consummation of the transactions contemplated
herein will: (a) violate any provision of the Certificate of Incorporation or Bylaws of Buyer; (b) conflict with, result in a breach of or constitute a default (or an event which, with or without notice, lapse of time or both, would
constitute a default) under, or give any third party the right to terminate or modify, any material agreement or other instrument to which Buyer is a party or by which it or any of its assets is bound; (c) conflict with, violate, result in a
breach of or constitute a default under any judgment, decree, order or process of any court or governmental authority; (d) conflict with or violate any material statute, law or regulation applicable to the business of Buyer; or (e) require
Buyer to obtain any authorization, consent, approval or waiver from, or to make any filing with, any governmental or regulatory authority. 
  

 12 

 5.4 Finders. Neither Buyer, nor any of its Affiliates, nor any of their respective directors or
officers, has taken any action that, directly or indirectly, would obligate Seller or any of its Affiliates to anyone acting as a broker, finder, financial advisor or in any similar capacity in connection with this Agreement or any of the
transactions contemplated hereby. 
 5.5 Disclosure. No representation, warranty or other statement by Buyer herein or made in writing
in connection herewith contains or will contain an untrue statement of a material fact, or omits or will omit to state a material fact necessary to make the statements contained herein or therein not misleading. 
 ARTICLE VI 
 COVENANTS 
 6.1 Obtaining Consents. Buyer and Seller shall use all reasonable efforts to obtain all consents, approvals and waivers from, and give all notices
to, and make all declarations, filings and registrations with, any governmental and regulatory agencies and other third parties that are required to consummate or are otherwise related to the transactions contemplated hereby. Buyer and Seller shall
coordinate and cooperate with one another and supply such assistance as may be reasonably requested by each in connection with the foregoing. 
 6.2 Transfer and Retention of Records. Except as may be required for tax purposes or other regulatory purposes, neither Seller, nor any of its respective successors and assigns, will retain any document, databases or other media
embodying any confidential or proprietary information relating to the HIV/AIDS Business or use, publish or disclose to any third person any such confidential or proprietary information relating to the HIV/AIDS business; provided,
however, that Seller shall be entitled to retain copies of any of the foregoing (and have access to the same after the Closing) to the extent necessary in connection with prosecuting or defending any matter not assumed by Buyer. Seller shall
take all actions requested by Buyer to transfer records relating to Seller’s business to Buyer, which may include making duplicate copies of any records retained by Seller in the form of paper or electronic media. 
 6.3 Employee Matters. Buyer shall not assume or be responsible in any way for the obligations, liabilities or responsibilities (a) of any
Employee Benefit Plan of Seller, (b) of Seller, any Affiliate of Seller or any fiduciary under, arising from, or with respect to any Employee Benefit Plan of Seller or (c) to any of Seller’s officers, directors, employees and agents,
arising from or related to the transactions contemplated by this Agreement. Buyer shall not be deemed to be a successor employer with respect to the employment of any employee of Seller or with respect to any of Seller’s Employee Benefit Plans.
Buyer shall not be obligated to offer employment to any or all of Seller’s employees. 
 6.4 Further Assurances. Buyer and Seller
shall, and shall cause their respective Affiliates to, at the request and the expense of the other, execute and deliver such other instruments of conveyance and transfer and assumption and take such other action as may be reasonably requested so as
to consummate the transactions contemplated hereby or otherwise to consummate the intent of this Agreement, Without limiting the generality of the foregoing, the Seller will, and will cause its management to, execute management representation
letters reasonably requested by 
  

 13 

 Buyer’s outside auditors in connection with the audit of Seller or otherwise as is required by applicable securities
laws. In addition, prior to or immediately after Closing, Buyer and Seller shall agree on the text of a letter to be sent to present HIV/AIDS patients who are customers of Seller, advising such patients that their records have been transferred to
Buyer. 
 6.5 Certain Covenants of Seller. Seller hereby covenants that (unless Buyer otherwise gives its written approval in its sole
discretion) Seller shall at its sole cost and expense take the actions set forth below: 
 (a) At the Closing, Seller shall pay or otherwise
discharge (in full, without discount or compromise) all the Excluded Liabilities related to the HIV/AIDS Business. 
 (b) After the Closing,
Seller shall afford Buyer, its attorneys, accountants, consultants and representatives, free and full access to the Acquired Assets and books and records of Seller relating thereto, at all reasonable times upon reasonable notice and during normal
business hours, and shall provide to Buyer and its representatives such additional financial and operating data and other information as Buyer shall from time to time reasonably request. 
 (c) After the Closing, Seller shall use its best efforts to preserve for Buyer the goodwill of its customers and suppliers, and shall do all things
reasonably requested by Buyer for such purpose. 
 (d) After the Closing, Seller shall promptly advise Buyer in writing of the commencement
or threat against Seller of any suit, litigation or legal proceeding that relates to or might affect the Acquired Assets. 
 ARTICLE VII 

 RESTRICTIVE COVENANTS 
 7.1 Non-Competition. Seller, Seller’s Shareholders, Hagop Youredjian and Zarig Youredjian hereby agree that as a material inducement to Buyer to enter into this Agreement, and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, Seller, each of Seller’s Shareholders, Hagop Youredjian, and Zarig Youredjian covenant and agree that it, and each of Seller’s officers, directors and Affiliates, and each of
Seller’s Shareholder’s Affiliates and immediate family members, as well as immediate family members of Hagop Youredjian and Zarig Youredjian shall not, for the period from the date hereof until five (5) years following the Closing
Date (the “Restricted Period”), directly or indirectly, (a) on its own behalf or in the service of or on the behalf of others, as a director, trustee, owner (except as the owner of less than two percent (2%) of the outstanding
stock of a publicly held corporation), employee, consultant, advisor, independent contractor or in any other capacity, engage in the business of operating, within seventy-five (75) miles of Seller’s present pharmacy in Glendale, California
(the ‘Restricted Territory”) a pharmacy that primarily services or treats, or primarily market or sells AIDS/HIV products to, AIDS/HIV patients or (b) permit a pharmacy that primarily services or treats, or primarily markets or sells
AIDS/HIV products to, AIDS/HIV patients to operate at the location of Seller’s present pharmacy in Glendale, California, or cooperate with or assist in any Person to engage in any such activities, including without limitation by
(i) selling or 
  

 14 

 otherwise transferring its business and assets (which may include its real property lease or a license to use same) to
any Person that may or is permitted to engage in any such activities and/or (ii) cooperating with or otherwise assisting any other Person to acquire a license to so engage in any such activities. For the sake of clarity, a pharmacy
“primarily services or treats, or primarily markets or sells AIDS/HIV products to, AIDS/HIV patients” if it either derives more than two percent (2%) of its revenues from the sale of AIDS/HIV services or products or in any way is
marketing its AIDS/HIV services or products specifically to the AIDS/HIV community. 
 7.2 Non-Interference. Seller, each of
Seller’s Shareholders and Hagop Youredjian further agree that, during the Restricted Period and within the Restricted Territory, Seller, each of Seller’s Shareholders and Hagop Youredjian will not, directly or indirectly; (i) induce
any former customer of or referrer of customers to Seller or customer of or referrer of customers to Buyer to patronize any Person who competes with Buyer; (ii) request or advise any former customer of or referrer of customers to Seller or
customer of or referrer of customers to Buyer to withdraw, curtail or cancel such Person’s business with Buyer; (iii) enter into any contract, the purpose or result of which would benefit such Seller if any former customer of or referrer
of customers to Seller or customer of or referrer of customers to Buyer were to withdraw, curtail, or cancel such customer’s or referrers business with Buyer; or (iv) disclose to any other Person the names or addresses of any former
customer of or referrers of customers to Seller or customer of or referrers of customers to Buyer, either individually or collectively. 
 7.3 Acknowledgements. If the provisions of this Article VII are violated, in whole or in part, Buyer shall be entitled, upon application to any court of proper jurisdiction, to a temporary restraining order or preliminary injunction
to restrain and enjoin Seller, each of Seller’s Shareholders and Affiliates, and Hagop Youredjian from such violation without prejudice as to any other remedies Buyer may have at law or in equity. In the event of a violation, Seller, each of
Seller’s Shareholders and Hagop Youredjian agree that it would be virtually impossible for Buyer to calculate its monetary damages and that Buyer would be irreparably harmed. If Buyer seeks such temporary restraining order or preliminary
injunction, Buyer shall not be required to post any bond with respect thereto, or, if a bond is required, it may be posted without surety thereon. If any restriction contained in this Article VII is held by any court to be unenforceable, or
unreasonable, as to time, geographic area or business limitation, Buyer, Seller, each of Seller’s Shareholders and Hagop Youredjian agree that such provisions shall be and are hereby reformed to the maximum time, geographic area or business
limitation permitted by applicable laws. The parties further agree that the remaining restrictions contained in this Article VII shall be severable and shall remain in effect and shall be enforceable independently of each other. Seller, each of
Seller’s Shareholders and Hagop Youredjian specifically acknowledge, represent and warrant that the covenants set forth in this Article VII are reasonable and necessary to protect the legitimate interests of Buyer, and that Buyer would not have
entered into this Agreement or paid the Purchase Price in the absence of such covenants. 
 ARTICLE VIII 
 INDEMNIFICATION 
 8.1 Survival of
Representations and Warranties. All representations and warranties contained in Articles IV and V of this Agreement shall survive the Closing for the applicable statute of limitations, except that the representations and warranties contained in
Sections 4.4, 4.5, 4.6, 4.7, 4.8, 4.9, 4.19, 4.20 and 4.22 shall survive for only two (2) years after the Closing Date. 
  

 15 

 8.2 Indemnification by Seller and Seller’s Shareholders. Seller and each of Seller’s
Shareholders shall indemnify and save Buyer and its Affiliates, their respective directors, officers, employees, agents and representatives and all of their successors and assigns (collectively “Buyer Claimants” and individually a
“Buyer Claimant”) harmless from and defend each of them from and against any and all demands, claims, actions, liabilities, losses, costs, damages or expenses whatsoever (including any reasonable attorneys’ fees) (collectively,
“Losses”) asserted against, imposed upon or incurred by Buyer Claimants resulting from or arising out of (a) any inaccuracy or breach of any representation or warranty of Seller and Seller’s Shareholders contained herein;
(b) any breach of any covenant or obligation of Seller contained herein; (c) any liability of Seller arising out of events occurring, conditions existing, products sold or activities of Seller; (d) noncompliance with any applicable
bulk sales or similar laws (including laws which may impose transferee liability on Buyer or an Affiliate of Buyer or create Encumbrances on the Acquired Assets relating to Seller’s liability for sales, use or other taxes or withholdings
arising out of the operations of Seller); and (e) any liability arising out of or related to Seller’s business prior to Closing, or the assertion against a Buyer Claimant of a claim which, if valid, would constitute a liability arising out
of or related to Seller’s business prior to Closing. Notwithstanding the foregoing, in no event shall the aggregate indemnification to be provided by Seller and Seller’s Shareholders solely in respect of matters referred to in clause
(a) above exceed the amount of the Purchase Price. 
 8.3 Indemnification by Buyer. Buyer shall indemnify and save Seller and its
respective Affiliates and their respective directors, officers, employees, agents and representatives (collectively “Seller Claimants” and individually a “Seller Claimant”) harmless from and defend each of them from and against
any and all Losses asserted against, imposed upon or incurred by Seller Claimants resulting from or arising out of (a) any inaccuracy or breach of any representation or warranty of Buyer contained herein; (b) any breach of any covenant or
obligation of Buyer contained herein; and (c) except as described in Section 8.2 above, Buyer’s ownership of the Acquired Assets and operation of its business from and after the Closing Date. 
 8.4 Indemnification Procedures. 
 (a)
The rights and obligations of each party claiming a right to indemnification hereunder (“Indemnitee”) from the other party (“Indemnitor”) shall be governed by the following rules: 
 (i) The Indemnitee shall give prompt written notice to the Indemnitor of any state of facts which Indemnitee determines will give rise to a claim by the
Indemnitee against the Indemnitor based on the indemnity agreements contained herein, stating the nature and basis of said claims and the amount thereof, to the extent known. No failure to give such notice shall affect the indemnification
obligations of Indemnitor hereunder, except to the extent such failure materially prejudices such Indemnitor’s ability successfully to defend the matter giving rise to the indemnification claim. 
  

 16 

 (ii) In the event any action, suit or proceeding is brought against the Indemnitee, with respect to
which the Indemnitor may have liability under the indemnity agreements contained herein, then upon the written acknowledgment by the Indemnitor within thirty days of the bringing of such action, suit or proceeding that it is undertaking and will
prosecute the defense of the claim under such indemnity agreements and confirming that the claim is one with respect to which the Indemnitor is obligated to indemnify and that it will be able to pay the full amount of potential liability in
connection with any such claim, the action, suit or proceeding (including all proceedings on appeal or for review which counsel for the Indemnitee shall deem appropriate) may be defended by the Indemnitor. However, in the event the Indemnitor shall
not offer reasonable assurances as to its financial capacity to satisfy any final judgment or settlement, the Indemnitee may assume the defense and dispose of the claim, after 30 days prior written notice to the Indemnitor. The Indemnitee shall have
the right to employ its own counsel in any such case, but the fees and expenses of such counsel shall be at the Indemnitee’s own expense unless (A) the employment of such counsel and the payment of such fees and expenses both shall have
been specifically authorized by the Indemnitor in connection with the defense of such action, suit or proceeding or (B) the Indemnitee shall have reasonably concluded and specifically notified the Indemnitor that there may be specific defenses
available to it which are different from or additional to those available to the Indemnitor. 
 (iii) In addition, in any event specified in
clause (B) of the second sentence of subparagraph (ii) above, the Indemnitor, to the extent made necessary by such different or additional defenses, shall not have the right to direct the defense of such action, suit or proceeding on
behalf of the Indemnitee. If Indemnitor and Indemnitee cannot agree on a mechanism to separate the defense of matters extending beyond the scope of indemnification, such matters shall be defended on the basis of joint consultation. 
 (iv) The Indemnitee shall be kept fully informed by the Indemnitor of such action, suit or proceeding at all stages thereof, whether or not it is
represented by counsel. The Indemnitor shall, at the Indemnitor’s expense, make available to the Indemnitee and its attorneys and accountants all books and records of the Indemnitor relating to such proceedings or litigation, and the parties
hereto agree to render to each other such assistance as they may reasonably require of each other in order to ensure the proper and adequate defense of any such action, suit or proceeding. 
 (v) The Indemnitor shall make no settlement of any claims which Indemnitor has undertaken to defend, without Indemnitee’s consent, unless the
Indemnitor fully indemnifies the Indemnitee for all losses, there is no finding or admission of violation of law by, or effect on any other claims that may be made against, the Indemnitee and the relief granted in connection therewith requires no
action on the part of and has no effect on the Indemnitee. 
 ARTICLE IX  
 MISCELLANEOUS 
 9.1 Expenses. Each party hereto shall pay its own
expenses incurred in connection with this Agreement, except as otherwise specified in this Agreement and except that all sales, transfer and other similar taxes, levies and charges that may be imposed, levied or assessed in connection with the
consummation of the transactions contemplated hereby shall be borne by Seller. 
  

 17 

 9.2 Amendment. This Agreement may not be terminated, amended, altered or supplemented except by a
written agreement executed by the parties hereto. 
 9.3 Entire Agreement. This Agreement, including the schedules hereto, and the
instruments and other documents delivered pursuant to this Agreement, contain the entire agreement of the parties relating to the subject matter of this Agreement and supersede all other agreements and understandings of any kind between the parties
respecting such subject matter. Each and every representation, warranty and covenant shall be deemed to include the information contained in the schedules thereto. 
 9.4 Waivers. Waiver by either party of either breach of or failure to comply with any provision of this Agreement by the other party shall not be construed as, or constitute, a continuing waiver of such
provision, or a waiver of any other breach of, or failure to comply with, any other provision of this Agreement. No waiver of any such breach or failure or of any term or condition of this Agreement shall be effective unless in a written notice
signed by the waiving party and delivered, in the manner required for notices generally, to each affected party. 
 9.5 Notices. All
notices, consents, directions, approvals, instructions, requests and other communications required or permitted by the terms of this Agreement to be given to any Person shall be in writing, and any such communication shall become effective five
Business Days after being deposited in the United States mails, certified or registered (return receipt requested), with appropriate postage prepaid for first class mail or, if delivered by hand or courier service or in the form of a telex, telecopy
or telegram, when received (if received during normal business hours on a Business Day, or if not, then on the next Business Day thereafter), and shall be directed to the following address or telex or telecopy number: 
 If to Seller: 
 H&H Drug Stores, Inc.

 3604 San Fernando Road 
 Glendale, California 91204 
 Telecopier:
                             
 With a copy to: 
 Law Offices of Alen
Petrossian 
 505 North Brand Boulevard, Suite 1460 
 Glendale, California 91204 
 Attention: Alen Petrossian 
 Telecopier: 818-242-7855 
 If to Buyer:

 Medicine Made Easy 
 1660
Walt Whitman Road 
 Melville, New York 11747 
 Attention: Mr. Mike Moran 
 Telecopier: 631-249-5863 
  

 18 

 With a copy to: 
 Nixon Peabody LLP 
 990 Stewart Avenue 
 Garden City, New York 11530 
 Attention:
Allan H. Cohen 
 Telecopier: 866-947-2070 
 or
to such other address as a party may have furnished to the other parties in writing in accordance herewith, except that notices of change of address shall only be effective upon receipt. Any notice which is so mailed shall be deemed delivered on the
fourth Business Day (or Days) after mailing; any notice which is transmitted by telecopier shall be deemed delivered when transmitted to the telecopier number specified above and acknowledgment of receipt of such facsimile is received. 

9.6 Counterparts. This Agreement may be executed in two or more counterparts, and by the different parties hereto in separate counterparts each
of which when executed shall be deemed to be an original, but all of which together shall constitute one and the same document. 
 9.7
Governing Law; Submission to Jurisdiction. This Agreement shall be governed by, and construed in accordance with, the law of the State of California, without regard to applicable principles of conflict of laws that might otherwise govern.

 9.8 Binding Effect; Assignment. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their
respective successors and assigns. Neither party shall assign or transfer this Agreement nor any right or obligation hereunder by operation of law or otherwise without the consent of the other party, except that Buyer may assign its rights under
this Agreement to an Affiliate of Buyer. 
 9.9 Severability. If any provision of this Agreement or any part of any such provision is
held under any circumstances to be invalid or unenforceable in any jurisdiction, then: (a) such provision or part thereof shall, with respect to such circumstances and in such jurisdiction, be deemed amended to conform to applicable laws so as
to be valid and enforceable to the fullest possible extent; (b) the invalidity or unenforceability of such provision or part thereof under such circumstances and in such jurisdiction shall not affect the validity or enforceability of such
provision or part thereof under any other circumstances or in any other jurisdiction; and (c) such invalidity or enforceability of such provision or part thereof shall not affect the validity or enforceability of the remainder of such provision
or the validity or enforceability of any other provision of this Agreement. Each provision of this Agreement is separable from every other provision of this Agreement, and each part of each provision of this Agreement is separable from every other
part of such provision. 
  

 19 

 9.10 Headings. The headings contained in this Agreement (including the schedules) are for
reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. 
 9.11 No Agency. Neither
party hereto shall be deemed hereunder to be an agent of, or partner or joint venture with, the other party hereto. 
 9.12 Third
Parties. Nothing herein is intended or shall be construed to confer upon or give to any person other than the parties hereto any rights or remedies under or by reason of this Agreement. 
 9.13 Passage of Title and Risk of Loss. Legal title, equitable title and risk of loss with respect to the Acquired Assets will not pass to Buyer
until the Acquired Assets are transferred at the Closing. 
  

 20 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement effective as of the date first above
written. 
  

			
	SELLER:
	
	H&H DRUG STORES, INC.
		
	By:	 	 /s/ Hagop Youredjian

		 	Hagop Youredjian, President
	
	SELLER’S SHAREHOLDERS:
	
	THE YOUREDJIAN FAMILY TRUST
		
	By:	 	 /s/ Hagop Youredjian

		 	Hagop Youredjian, Trustee
		
	By:	 	 /s/ Zarig Youredjian

		 	 Zarig Youredjian, Trustee
 AND ZARIG YOUREDJIAN,
INDIVIDUALLY

	
	H&H DRUG STORES, INC.
	EMPLOYEE STOCK OWNERSHIP TRUST
		
	By:	 	 /s/ Kjersti Cory

		 	Kjersti Cory, Trust Officer
		 	First Bankers Trust Services, Inc.
	
	 /s/ HAGOP YOUREDJIAN

	HAGOP YOUREDJIAN
	
	BUYER:
	
	MEDICINE MADE EASY
		
	By:	 	 /s/ Michael Moran

		 	Michael Moran
		 	President and Chief Executive Officer

  

 21 

 EXHIBIT A 
 1. Seller has been duly organized and is validly existing and in good standing under the laws of the State of California. Seller has the power and authority to own, lease and operate its properties and to conduct its
business as it is presently conducted. Seller’s Shareholders are the only shareholders of Seller. 
 2. Seller and each of Seller’s
Shareholders have the power and authority to execute, deliver and perform, and has taken all action necessary to execute, deliver and perform the Agreement. Seller and each of Seller’s Shareholders have duly executed and delivered the
Agreement. 
 3. The Agreement constitutes the valid and binding obligation of Seller and each of Seller’s Shareholders, enforceable
against such Person in accordance with its terms. 
 4. The execution and delivery of the Agreement, and the consummation by Seller and each
of Seller’s Shareholders of the transactions contemplated by the Agreement, do not, with or without the giving of notice or the lapse of time or both, (a) violate (i) the articles of incorporation or bylaws of Seller, (ii) any
Federal or state law or regulation applicable to Seller or Seller’s Shareholders, or (iii) any existing obligation of the Seller or Seller’s Shareholders under any order, writ, judgment or decree of any court or Federal or state
governmental authority, or (b) violate or result in a breach of, constitute a default under, require any consent under, or result in the creation of a lien, charge or encumbrance on any property or assets of the Seller pursuant to, the terms of
any material agreement or instrument to which the Seller or either of Seller’s Shareholders is a party or is bound. 
 5. No
registration, approval, authorization, consent, notice or other action by, or filing with, any Federal or state governmental authority is required on the part of Seller or either of Seller’s Shareholders in connection with the execution and
delivery of the Agreement, or the consummation by Seller or either of Seller’s Shareholders of the transactions contemplated by the Agreement, or if required, such appropriate action has been taken. 
  

 22USAccess Bank, Inc. (now known as PBI Bank) 2000 Stock Option Plan

 Exhibit 10.1 
 USACCESS BANK, INC. 
 2000 STOCK OPTION PLAN 
 Section 1 — PURPOSE 
 USAccess Bank, Inc. (the “Company”) hereby establishes a stock option plan (the “Plan”) for the benefit of employees, as set forth below. 
 The Company adopts this compensation program for certain key employees to, among other things, (a) increase the profitability and growth of the Company; (b) provide competitive compensation to employees
while obtaining the benefits of tax deferral; (c) attract and retain exceptional personnel and encourage excellence in the performance of individual responsibilities; and (d) motivate key employees to contribute to the Company’s
success. 
 Section 2 — DEFINITIONS 
 For purposes of the Plan, the following terms shall have the meanings below unless the context clearly indicates otherwise: 
 2.1 “Affiliate” means any Subsidiary, Porter Bancorp, Inc., a 50% or more owned (direct or indirect) subsidiary of Porter Bancorp, or any other Parent corporation of the Company or a brother-sister
corporation that is 50% or more owned by a common parent or common individual shareholders of the Company. 
 2.2 “Board”
means the Board of Directors of the Company. 
 2.3 “Change of Control” of the Company means (i) an event or series of
events (other than an event described in (iii) below) which have the effect of any “person” as such term is used in Section 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
other than J. Chester Porter, Maria L. Bouvette, or any trustee or other fiduciary holding securities of the Company under any employee benefit plan of the Company, becoming the “beneficial owner” as defined in Rule 13d-3 under the
Exchange Act, directly or indirectly, of securities of the Company representing 50% or more of the combined voting power of the Company’s then outstanding stock; (ii) during any period of two consecutive years, individuals who at the
beginning of such period constitute the Board cease for any reason to constitute a majority thereof, unless the election, or the nomination for election by the stockholders, of each new director was approved by a vote of at least two-thirds of the
directors then still in office who were directors at the beginning of the period; or (iii) the shareholders of the Company approve a definitive agreement to merge or consolidate the Company with or into another company (other than a merger or
consolidation that would result in the voting securities of the Company outstanding immediately prior to such transaction continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity)
more than 50% of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such transaction) or to sell or otherwise transfer all or substantially all of the Company’s assets or to
adopt a plan of liquidation. 

 2.4 “Code” means the Internal Revenue Code of 1986, as it may be amended from time to
time. 
 2.5 “Committee” means the committee appointed by the Board pursuant to Section 4.1 to administer the Plan, if
any. If no committee has been appointed, Committee means the Board. 
 2.6 “Company” means USAccess Bank, Inc., and its
successors. 
 2.7 “Director” means a voting member of the Board, excluding any person who serves solely in an advisory
capacity or as a director emeritus. 
 2.8 “Disability” means permanent disability within the meaning of
Section 22(e)(3) of the Code. 
 2.9 “Employee” means an employee of the Company, its Parent, its Subsidiaries, or any
other Affiliates. 
 2.10 “Fair Market Value” has the meaning specified in Section 5.2. 
 2.11 “Incentive Stock Option” means an Option to purchase Stock granted under Section 5 of the Plan which is designated as an
Incentive Stock Option and is intended to meet the requirements of Section 422 of the Code. 
 2.12 “Independent
Director” means a Director who is not a current or former employee or officer of the Company or an Affiliate, and who does not receive any direct or indirect remuneration from the Company or any Affiliate for service to the Company or an
Affiliate in any capacity other than as a Director. 
 2.13 “Nonqualified Stock Option” means an option to purchase Stock
granted under Section 5 of the Plan which is not intended to be an Incentive Stock Option. 
 2.14 “Option” means an
Incentive Stock Option or a Nonqualified Stock Option. 
 2.15 “Option Period” means the period from the date of the grant
of an Option to the date when the Option expires as stated in the terms of the Stock Option Agreement. 
 2.16 “Optionee”
means an Employee or former Employee who has been granted an Option to purchase shares of Stock under the provisions of the Plan. 
  

 2 

 2.17 “Parent” or “Parents” means any corporation which at the time qualifies
as a parent of the Company under the definition of “parent corporation” in Section 424(e) of the Code. 
 2.18
“Plan” means this USAccess Bank, Inc. 2000 Stock Option Plan. 
 2.19 “Retirement” means Termination of
Employment with the Company or any of its Affiliates after attaining age 65 (or earlier with the Company’s or the Affiliate’s consent). 
 2.20 “Stock” means the Company’s common stock without par value or such other securities into which the Stock may be converted, by merger or otherwise. 
 2.21 “Stock Option Agreement” means an agreement between an Optionee and the Company covering the specific terms and conditions of an
Option. 
 2.22 “Subsidiary” or “Subsidiaries” means any corporation which at the time qualifies as a subsidiary
of the Company under the definition of “subsidiary corporation” in Section 424(f) of the Code. 
 2.23 “Termination of
Employment” will be deemed to have occurred at the close of business on the last day on which an Employee is carried as an active employee on the records of the Company or an Affiliate. The Committee shall determine whether an authorized
leave of absence, or other absence on military or government service, constitutes severance of the employment relationship between the Company or an Affiliate and the Employee. If a corporation ceases to be an Affiliate, a Termination of Employment
will be deemed to have occurred for all employees of such corporation at the close of business on the last day of affiliation. 
 Section 3 — STOCK SUBJECT TO THE PLAN 
 3.1 Authorized Stock. The aggregate number of shares of
Stock subject to an Option under the Plan at any point in time shall not exceed 775,050 shares of Stock for Optionees as adjusted pursuant to Section 3.3 below. Stock delivered under the Plan may consist, in whole or in part, of authorized and
unissued shares or shares acquired from shareholders upon such terms as the Board deems appropriate for reserve in connection with exercises hereunder. 
 3.2 Effect of Expirations. If any Option granted under the Plan expires or terminates without exercise, the Stock no longer subject to such Option shall be available to be re-awarded under the Plan. 

3.3 Adjustments in Authorized Shares. In the event of any merger, reorganization, consolidation, recapitalization, separation, liquidation,
stock dividend, split-up, share combination, or other change in the corporate structure of the Company affecting the number of shares of Stock or the kind of shares or securities issuable upon exercise of an Option, an appropriate and 
  

 3 

 proportionate adjustment shall be made by the Committee in the number and kind of shares which may be delivered under the
Plan, and in the number and kind of or price of shares subject to outstanding Options. Any adjustment of an Incentive Stock Option under this Section shall be made in such a manner so as not to constitute a “modification” within the
meaning of Section 424(h) of the Code. If the Company shall at any time merge, consolidate with or into another corporation or association, or enter into a statutory share exchange or any other similar transaction in which shares of Stock are
converted as a matter of law into securities and/or other property, each Optionee will thereafter receive, upon the exercise of an Option, the securities or property to which a holder of the number of shares of Stock then deliverable upon the
exercise of such Option would have been entitled if such Option had been exercised immediately prior to such merger, consolidation, or share exchange, and the Company shall take such steps in connection with such merger, consolidation or share
exchange as may be necessary to assure that the provisions of this Plan shall thereafter be applicable, as nearly as is reasonably possible, in relation to any securities or property thereafter deliverable upon the exercise of such Option.

 Section 4 — ADMINISTRATION 
 4.1 Committee Governance. This Plan shall be administered by the Board, until the Board appoints a Committee to carry out its administrative duties hereunder, which Committee shall consist solely of two or more
Independent Directors appointed by the Board. The number of Committee members shall be determined by the Board; provided that the Committee shall consist of at least two persons. The Board shall add or remove members from the Committee as the Board
sees fit, and vacancies shall be filled by the Board. The Committee shall select one of its members as the chairperson of the Committee and shall hold meetings at such times and places as it may determine. The Committee may appoint a secretary and,
subject to the provisions of the Plan and to policies determined by the Board, may make such rules and regulations for the conduct of its business as it shall deem advisable. Written action of the Committee may be taken by a majority of its members,
and actions so taken shall be fully effective as if taken by a vote of a majority of the members at a meeting duly called and held. A majority of Committee members shall constitute a quorum for purposes of a meeting. The act of a majority of the
members present at any meeting for which there is a quorum shall be a valid act of the Committee. 
 4.2 Committee to Interpret Plan.
Subject to the express terms and conditions of the Plan, the Committee shall have sole power to (i) construe and interpret the Plan; (ii) establish, amend or waive rules and regulations for its administration; (iii) to determine and
accelerate the exercisability of any Option; (iv) to correct inconsistencies in the Plan or in any Stock Option Agreement, or any other instrument relating to an Option; and (v) subject to the provisions of Section 7, to amend the
terms and conditions of any outstanding Option, to the extent such terms and conditions are within the discretion of the Committee as provided in the Plan. Notwithstanding the foregoing, no action of the Board or the Committee may, without the
consent of the person or persons entitled to exercise any outstanding Option, adversely affect the rights of such person or persons. 
  

 4 

 4.3 Exculpation. No member of the Board or the Committee shall be liable for actions or
determinations made in good faith with respect to the Plan, or for awards under it. 
 4.4 Selection of Employee Optionees. The
Committee shall have the authority to grant Options from time to time to such Employees as may be selected by it in its sole discretion. 
 4.5 Decisions Binding. All determinations and decisions made by the Board or the Committee pursuant to the provisions of the Plan, including factual determinations, shall be final, conclusive and binding on all persons, including the
Company, its Subsidiaries and affiliates, its shareholders, Optionees and their estates and assignees. 
 4.6 Stock Option Agreements.
Each Option under the Plan shall be evidenced by a Stock Option Agreement which shall be signed by the Chairman or Secretary of the Committee and by the Optionee, and shall contain such terms and conditions as may be approved by the Committee, which
need not be the same in all cases. Any Stock Option Agreement may be supplemented or amended in writing from time to time as approved by the Committee, provided that the terms of such Agreements as amended or supplemented, as well as the terms of
the original Stock Option Agreement, are not inconsistent with the provisions of the Plan. An Employee who receives an Option under the Plan shall not, with respect to the Option, be deemed to have become an Optionee, or to have any rights with
respect to the Option, unless and until a Stock Option Agreement has been signed by the Chairman or Secretary of the Committee and by the Employee and delivered to the Committee, and the Employee has otherwise complied with the applicable terms and
conditions of the Option. The Committee may condition any Option grant upon the agreement by the Optionee to such confidentiality, non-competition and non-solicitation covenants as the Committee deems appropriate. 
 4.7 Limitation on Exercise of Options. No part of an Option may be exercised to the extent the exercise would cause Optionee to have compensation
from the Company and its affiliated companies for any year in excess of $1 million and which is nondeductible by the Company and its affiliated companies pursuant to Code Section 162(m). Any portion of an Option not exercisable because of this
limitation shall continue to be exercisable in any subsequent year in which the exercise would not cause the loss of the Company’s or its affiliated companies’ compensation tax deduction, provided such exercise occurs before lapse of the
Option, and otherwise complies with the terms and conditions of the Plan and Stock Option Agreement. 
 4.8 Required Exercise or
Forfeiture. Notwithstanding any other provision of this Plan or any Stock Option Agreement to the contrary, the primary federal regulator of the Company or any Affiliate may direct the Board or the Committee to require that Plan participants
exercise or forfeit their Options if the institution’s capital falls below the minimum requirements as determined by its primary state or federal regulator. 
  

 5 

 Section 5 — GRANT OF OPTIONS  
 5.1 Eligibility and Grant. Employees of the Company and its Affiliates who are expected to contribute substantially to the growth and
profitability of the Company and its Subsidiaries or have provided significant services in the initial organization of the Company are eligible for selection by the Committee under Section 4.4 to receive Options. Both Incentive Stock Options
and Nonqualified Stock Options may be granted under the Plan, provided that only employees of the Company, its Parents, and its Subsidiaries are eligible for Incentive Stock Options. If an Option is designated as an Incentive Stock Option but does
not qualify or ceases to qualify as such under Section 422 of the Code, the Option (or portion thereof) shall be treated as a Nonqualified Stock Option and governed by Section 83 of the Code. Neither the Company nor any of its Affiliates
will be liable for tax consequences of an Option, including but not limited to the failure of an Option intended to be an Incentive Stock Option to qualify as such. An Incentive Stock Option that is not exercised within three months of the date an
individual ceases to be an employee of the Company, its Parent, or its Subsidiaries shall cease to qualify as an Incentive Stock Option. All Options granted to Employees under the Plan shall be evidenced by a Stock Option Agreement in such form as
the Committee may from time to time approve. All Options are subject to the terms and conditions of the Plan and such additional terms and conditions contained in the Stock Option Agreement, which need not be the same in each case, not inconsistent
with the terms of the Plan, as the Committee finds desirable. 
 5.2 Exercise Price. The purchase price per share of Stock covered by
an Option shall be determined by the Committee but shall not be less than 100% of the Fair Market Value of such Stock on the date the Option is granted. The Fair Market Value shall be determined by the Committee in its sole discretion, provided
that, if the Company’s Stock is publicly traded on an established securities market, the Fair Market Value shall be the closing market price of the Company’s Stock as reported on the date of grant, or, if no trades were reported on that
date, the closing price on the most recent trading day immediately preceding the date of the grant. An Incentive Stock Option granted to any person who, at the time the Option is granted, owns or is deemed to own within the meaning of
Section 424(d) of the Code, more than 10% of the total combined voting power of all classes of stock of the Company, shall have an exercise price which is at least 110% of the Fair Market Value of the Stock subject to the Option. 
 5.3 Option Period. The Option Period shall be determined by the Committee, but no Option shall be exercisable later than ten years from the date
of grant. Notwithstanding the foregoing, in the case of an Optionee owning (within the meaning of Section 424(d) of the Code), at the time an Incentive Stock Option is granted, more than 10% of the total combined voting power of all classes of
stock of the Company, any Parent, or any Subsidiary, such Incentive Stock Option shall not be exercisable later than five years from the date of grant. No Option may be exercised at any time unless such Option is valid and outstanding as provided in
this Plan. 
 5.4 Limitation on Amount of Incentive Stock Options. The aggregate Fair Market Value (determined as of the time the
Option is granted) of the Stock with respect to which a Optionee’s Incentive Stock Options are exercisable for the first time during any calendar year 
  

 6 

 (under this and all other stock option plans of the Company, any Parent, and any Subsidiary) shall not exceed $100,000.
Options or portions of Options exercisable as a result of acceleration under Section 9.8 in excess of the $100,000 limit described herein shall be treated as a Nonqualified Stock Option for tax purposes. 
 5.5 Limitation to Parents and Subsidiaries. In the event a corporation ceases to qualify as a Parent or Subsidiary under Code Section 424 but
continues to be an Affiliate, any Incentive Stock Option previously granted to an Employee of such corporation and remaining outstanding shall continue to qualify as an Incentive Stock Option for three months from such date, after which the option
shall be a Nonqualified Stock Option under the terms of this Plan. 
 SECTION 6 — EXERCISE OF OPTIONS 
 6.1 Exercise. An Option may be exercised, so long as it is valid and outstanding, from time to time in part or as a whole, subject to any
limitations with respect to the number of shares for which the Option may be exercised at a particular time and to such other conditions (e.g., exercise could be conditioned on performance) as the Committee in its discretion may specify upon
granting the Option or as otherwise provided in this Section 6. 
 6.2 Method of Exercise. To exercise an Option, the Optionee or
the other person(s) entitled to exercise the Option shall give written notice of exercise to the Committee, specifying the number of shares to be purchased. Such notice shall be accompanied (1) by payment in full in cash for the Stock being
purchased plus, in the case of a Nonqualified Stock Options issued to an Employee, any required withholding tax as provided in Section 10, (2) if permitted by the Committee in its sole discretion, payment in full or in part made in the
form of Stock owned by the Optionee for at least 6 months (based on the Fair Market Value of the Stock on the date the Option is exercised) evidenced by negotiable Stock certificates registered either in the sole name of the Optionee or the names of
the Optionee and spouse, or (3) by any combination of cash under (1) and stock under (2). No shares of Stock shall be issued unless the Optionee has fully complied with the provisions of this Section 6.2. 
 6.3 Exercise After Termination of Employment. This Section 6.3 applies to Options granted to Employees. 
  

	 	(a)	After an Employee’s Termination of Employment other than for Cause, an Option may be exercised, subject to adjustment as provided in Section 3.3, only with respect to the
number of shares of Stock which the Employee could have acquired by an exercise of the Option immediately before the Termination of Employment but in no event after the expiration date of the Option as specified in the applicable Stock Option
Agreement. Except to the extent shorter or longer periods are provided in the Stock Option Agreement by the Committee, or to the extent longer periods are provided by the Committee after the date an Option is granted, an Employee’s right to
exercise an Option upon Termination of Employment shall terminate: 

  

 7 

	 	(i)	At the expiration of three months (Incentive Stock Options) or one year (Nonqualified Stock Options) after the Employee’s Retirement; provided, however, if an Incentive Stock
Option is not exercised after three months, it will remain exercisable and be treated as a Nonqualified Stock Option for purposes of the Plan when it is exercised; or 

  

	 	(ii)	At the expiration of one year in the event of Disability of the Employee; or 

  

	 	(iii)	At the expiration of one year after the Employee’s death if the Employee’s Termination of Employment occurs by reason of death; any Option exercised under this
subparagraph (iii) may be exercised in full by the legal representative of the estate of the Employee or by the person or persons who acquire the right to exercise such Option by bequest or inheritance; or 

  

	 	(iv)	No later than three months after the Employee’s Termination of Employment for any other reason. 

  

	 	(b)	In the event the Committee determines that an Employee’s employment is terminated for Cause, the Employee shall forfeit any and all unexercised Options immediately upon the
Termination of Employment. For purposes of this Plan, “Cause” shall mean the Employee’s (i) willful failure to substantially perform such Employee’s reasonably assigned duties on behalf of the Company, (ii) illegal
conduct in performing such Employee’s duties, (iii) willful actions contrary to the Company’s interest, or (iv) violation of the obligations imposed on the Employee under any confidentiality or solicitation covenants to which the
Employee is bound under the terms of the Stock Option Agreement or otherwise. 

 6.4 Change in Control. In the event of
a Change of Control resulting in the Shareholders of the Company receiving cash for their shares, the Committee may, in its sole discretion, pay to an Optionee in cash and in lieu of the exercise of such Option, within a reasonable amount of time
following the Change of Control, even though such payment might accelerate taxation of benefits hereunder, the then value of the Nonqualified Stock Option or Incentive Stock Option, based on the difference between the then Fair Market Value of the
Stock less the exercise price to the extent such difference is a positive number. Such payment shall be in complete satisfaction of the Optionee’s rights under the Plan. If the value of such an Option is negative and no payment is made, the
Optionee’s rights shall nonetheless be extinguished. 
  

 8 

 Section 7 — AMENDMENTS AND TERMINATION 
 7.1 Amendments and Termination. The Board or the Committee may terminate, suspend, amend or alter the Plan, but no action of the Board or the
Committee may: 
  

	 	(a)	impair or adversely affect the rights of an Optionee under an Option, without the Optionee’s consent; and 

  

	 	(b)	Without the approval of the shareholders: 

  

	 	(i)	increase the total amount of Stock which may be delivered under the Plan except as is provided in Section 3 of the Plan; 

  

	 	(ii)	decrease the option price of any Option to less than the option price on the date the Option was granted; 

  

	 	(iii)	extend the maximum Option Period, or 

  

	 	(iv)	extend the period during which Options may be granted, as specified in Section 12. 

 7.2 Conditions on Options. In granting an Option, the Committee may establish any conditions that it determines are consistent with the purposes and provisions of the Plan, including, without limitation, a
condition that the granting of an Option is subject to the surrender for cancellation of any or all outstanding Options held by the Optionee. Any new Option made under this section may contain such terms and conditions as the Committee may
determine, including an exercise price that is lower than that of any surrendered Option. 
 7.3 Selective Amendments. Any amendment
or alteration of the Plan may be limited to, or may exclude from its effect, particular classes of Optionees. 
 Section 8 —
RESTRICTIONS ON TRANSFER 
 8.1 Restriction on Transfer. No Optionee shall sell, assign, transfer or otherwise dispose of
any of the Stock issued to him upon the exercise of an Option (“Option Stock”) until (i) he has delivered to the Company an irrevocable written offer to sell any such shares of Option Stock at any time within 60 days after delivery of
the offer and at a price per share equal to Fair Value, and (ii) the Company shall have failed to accept such offer within the 60-day period, in which case the Stock may be sold by the Optionee on the terms offered to the Company within 60 days
of the earlier of the expiration of the Company’s 60 day acceptance period or the date the Company notifies the Optionee that it will not exercise its right to purchase the Stock. A bona fide written offer from an independent prospective buyer
shall be deemed to be the Fair Value solely for purposes of this Section 8.1. To accept the offer, the Company shall deliver notice of its acceptance of its offer within 60 days after delivery of offer. Payment for the offered Option Stock
shall be on terms no less favorable to Optionee than those set forth in the bona fide written offer. 
  

 9 

 8.2 Termination of Employment. If an Optionee’s employment with the Company and its
Affiliates is terminated for any reason, the Company may, at its option, for a one year period following the later of such termination or the exercise of an Option but in no event earlier than 6 months after the exercise of an Option, purchase such
Optionee’s Option Stock at the Fair Value of the Stock, which shall be based on a valuation of the Company’s Stock based on an appraisal by an independent appraiser selected and paid by the Company, who shall make such determination as of
the Company’s most recent fiscal year end, divided by the total number of shares of Stock outstanding as of the date of determination. The Company shall make payment in cash for any Option Stock that it purchases pursuant to this
Section 8.2 within 30 days after the date the Company delivers notice of its exercise of its right to purchase the Option Stock. The Optionee shall surrender certificates representing the offered Option Stock at the time the Company makes such
payment. 
 8.3 Restriction on Pledge. No Optionee shall, without the prior written consent of the Company, pledge, mortgage or
otherwise encumber any of his Option Stock. 
 8.4 Termination of Restrictions. The restrictions imposed by this Section 8 shall
not apply (i) to the transfer by operation of law to a deceased Optionee’s personal representative of the Optionee’s interest in the Option Stock, and (ii) at any time after the closing of the issuance of the Company’s
shares of Stock to the public pursuant to an initial public offering registered with the U.S. Securities and Exchange Commission, and (iii) at any time after a Change in Control results in the Option Stock being converted into the stock of
another entity, which stock has a public securities market. 
 Section 9 — GENERAL PROVISIONS 
 9.1 Unfunded Status of Plan. The Plan is intended to constitute an “unfunded” plan for incentive compensation, and the Plan is not
intended to constitute a plan subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended, and shall not extend, with respect to any payments not yet made to an Optionee, any rights that are greater than those of a
general creditor of the Company. 
 9.2 Transfers, Leaves of Absence and Other Changes in Employment Status. For purposes of the Plan
(i) a transfer of an Employee from the Company to an Affiliate, or vice versa, or from one Affiliate to another; or (ii) a leave of absence, duly authorized in writing by the Company or an Affiliate, for military service or sickness, or
for any other purpose approved by the Company or an Affiliate if the period of such leave does not exceed 90 days; or (iii) any leave of absence in excess of 90 days approved by the Company, shall not be deemed a Termination of Employment. The
Committee, in its sole discretion subject to the terms of the Stock Option Agreement, shall determine the disposition of all Options made under the Plan in all cases involving any substantial change in employment status other than as specified
herein. 
  

 10 

 9.3 Restrictions on Distribution of Stock. The Committee may require Optionees receiving Stock
pursuant to any Option under the Plan to represent to and agree with the Company in writing that the Optionee is acquiring the Stock for investment without a view to distribution thereof. No Stock shall be issued or transferred pursuant to an Option
unless the Committee determines, in its sole discretion, that such issuance or transfer complies with all relevant provisions of law, including but not limited to, the (i) limitations, if any, imposed in the state of issuance or transfer,
(ii) restrictions, if any, imposed by the Securities Act of 1933, as amended, the Exchange Act, and the rules and regulations promulgated thereunder, and (iii) requirements of any stock exchange upon which the Stock may then be listed. The
certificates for Stock issued pursuant to exercise of an Option may include any legend that the Committee deems appropriate to reflect any restrictions on transfer. The Company shall not be obligated to register any securities covered hereby or to
take any affirmative action in order to cause the issuance of Stock pursuant to exercise of an Option to comply with any law or regulation. 
 9.4 Assignment Prohibited. Subject to the provisions of the Plan and the Stock Option Agreement (if any), no Option shall be assigned, transferred, pledged or otherwise encumbered by the Optionee otherwise than by will or by the laws
of descent and distribution, and such Options shall be exercisable, during the Optionee’s lifetime, only by the Optionee. Options shall not be pledged or hypothecated in any way, and shall not be subject to any execution, attachment, or similar
process. Any attempted transfer, assignment, pledge, hypothecation or other disposition of an Option contrary to the provisions of the Plan, or the levy of any process upon an Option, shall be null, void and without effect. 
 9.5 Other Compensation Plans. Nothing contained in the Plan shall prevent the Company from adopting other compensation arrangements. 

9.6 Limitation of Authority. No person shall at any time have any right to receive an Option hereunder and no person shall have authority to
enter into an agreement on behalf of the Company for the granting of an Option or to make any representation or warranty with respect thereto, except as granted by the Board or the Committee. Optionees shall have no rights in respect to any Option
except as set forth in the Plan and the applicable Stock Option Agreement (if any). 
 9.7 No Right to Employment. Neither the action
of the Company in establishing the Plan, nor any action taken by it or by the Board or the Committee under the Plan or any Stock Option Agreement, or any provision of the Plan, shall be construed as giving to any person the right to be retained in
the employ of the Company or any other entity. 
 9.8 Change of Control. If granted by the Committee in the Stock Option Agreement, in
the event of a Change of Control, Options granted under the Plan shall become exercisable in full whether or not otherwise exercisable at such time, and any such Option shall remain exercisable in full thereafter until it expires pursuant to its
terms. 
  

 11 

 9.9 Not a Shareholder. The person or persons entitled to exercise, or who have exercised, an
Option shall not be entitled to any rights as a shareholder of the Company with respect to any Stock subject to the Option until such person or persons shall have become the holder of record of such shares. 
 9.10 Headings. The headings in this Plan have been inserted solely for convenience of reference and shall not be considered in the interpretation
or construction of this Plan. 
 9.11 Governing Law. The validity, interpretation, construction and administration of this Plan shall
be governed by the laws of the Company’s state of incorporation, as it may change from time to time. 
 9.12 Severability. If any
provision of this Plan is found to be illegal or unenforceable by any court of competent jurisdiction, the remaining provisions hereof shall be severable and enforceable in accordance with their terms, and all provisions shall remain enforceable in
any other jurisdiction. 
 Section 10 — TAXES 
 10.1 Tax Withholding. All Optionees shall make arrangements satisfactory to the Committee to pay to the Company, at the time of exercise in the
case of a Nonqualified Stock Option, any federal, state or local taxes required to be withheld with respect to such shares. If an Optionee fails to make such tax payments, the Company and its Affiliates shall, to the extent permitted by law, have
the right to deduct any such taxes from any payment of any kind otherwise due to the Optionee. 
 10.2 Share Withholding. If permitted
by the Committee, a tax withholding obligation may be satisfied by the Company retaining shares of Stock with a fair market value equal to the statutory minimum amount of federal, state or local tax required to be withheld. Any Stock so withheld
will not be counted against the number of shares available for issuance under Section 3.1 of the Plan. 
 Section 11 —
EFFECTIVE DATE OF PLAN 
 The Plan shall be effective on the date (the “Effective Date”) when the Board adopts the Plan,
subject to approval of the Plan by a majority of the total votes eligible to be cast at a meeting of shareholders following adoption of the Plan by the Board, which vote shall be taken within 12 months of the Effective Date; provided, however, that
Options may be granted before obtaining shareholder approval of the Plan, but any such Options shall be contingent upon such shareholder approval being obtained and may not be exercised before such approval. 
  

 12 

 Section 12 — TERM OF PLAN 
 Unless terminated earlier by the Committee, no Option shall be granted under the Plan more than ten years after the Effective Date as defined in
Section 11. 
 * * * * * 
  

 13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00101-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00101-of-00352.parquet"}]]